Spain will soon have another drug to fight obesity. After Ozempicwill arrive in our country wegovy. Developed by Novo Nordisk, it contains as an active ingredient semaglutide, useful for reducing and controlling blood sugar levelsas well as regulating insulin.
It is not yet covered by the National Health System and, according to the Spanish Agency for Medicines and Health Products (AEMPS), the drug will be subject to additional monitoring. In fact, the Danish pharmaceutical company indicated that supply will be carried out in a “limited and responsible” manneras a consequence of an “unprecedented large global demand.”
Despite this drawback, Novo Nordisk is working to increase its production of semaglutide to be able to manufacture more units of this drug. To do this, it will expand its production plants and “operate at full capacity.” It is an analogue of glucagon-like peptide 1 (GLP-1), produced by recombinant DNA technology in cells of Saccharomyces cerevisiae.
This medication requires a prescription to purchase, since it is not financed by the State. According to the AEMPS, it is indicated, in the case of adults, as “complement to a low-calorie diet and increased physical activity for weight control, including weight loss and maintenance” in adults with a Body Mass Index (BMI) greater than 30 kg/m2″.
Administered once a week
Administered subcutaneously, Wegovy is applied once a week at any time of the daywith or without food. The recommended dose is 2.4 mg. Treatment will begin with a low dose that will be gradually increased over 16 weeks of treatment. The initial dose is 0.25 mg once a week, gradually increasing the dose to reach the recommended dose.
Do not administer intravenously or intramuscularly
The European Comission also warns of Do not administer this medication either intravenously or intramuscularly.. Later, they remembered the following. “Semaglutide should be used with caution in patients treated with oral medications that require rapid gastrointestinal absorption.”
The AEMPS also launched a notice about the drug. “Once you reach the recommended dose of 2.4 mg, do not increase this dose further. If you feel very bothered by nausea or vomiting, talk to your doctor about delaying dose escalation or going down to the previous dose until your symptoms have improved.”
Follow the Diario AS channel on WhatsAppwhere you will find all the sport in a single space: the current news of the day, the agenda with the latest news of the most important sporting events, the most outstanding images, the opinion of the best AS brands, reports, videos, and some humor from time to time.
